Your browser doesn't support javascript.
loading
Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
Bauditz, J; Haemling, J; Ortner, M; Lochs, H; Raedler, A; Schreiber, S.
Affiliation
  • Bauditz J; Charité University Hospital, 4th Department of Medicine/Mucosal, Berlin, Germany.
Gut ; 40(4): 470-4, 1997 Apr.
Article in En | MEDLINE | ID: mdl-9176073
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pentoxifylline / Phosphodiesterase Inhibitors / Prednisolone / Crohn Disease / Tumor Necrosis Factor-alpha / Anti-Inflammatory Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Gut Year: 1997 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pentoxifylline / Phosphodiesterase Inhibitors / Prednisolone / Crohn Disease / Tumor Necrosis Factor-alpha / Anti-Inflammatory Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Gut Year: 1997 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido